Firefly Neuroscience cuts authorized shares to 101 million; holders approve plan increase
At its August 5, 2026 annual meeting, Firefly Neuroscience stockholders approved reducing the company's authorized shares from 5,001,000,000 to 101,000,000, effective the same day. They also approved adding 2,000,000 shares to the 2024 Long-Term Incentive Plan and updating its evergreen provision, which affects potential future share issuance to employees and directors.
Key points
- Authorized shares cut from 5,001,000,000 to 101,000,000 (100,000,000 common and 1,000,000 preferred), effective August 5, 2026
- 2024 Long-Term Incentive Plan share limit raised by 2,000,000 shares, with evergreen provision updated
- Arun Menawat elected Class III director with 4,324,584 votes for and 106,395 withheld
- Quorum of 9,703,536 of 15,604,571 shares outstanding as of the June 8, 2026 record date
The filing
Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 07, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.